Clinical Trial Update: REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 randomized exploratory trial (REVIVE) evaluating a stem cell product for safety and effectiveness in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Cirrhosis

Drugs mentioned

• Stem Cell Product

Snippet

Sponsor: Pharmicell Co., Ltd. | Conditions: Alcoholic Liver Cirrhosis | Phase 2 | Status: COMPLETED